Integra LifeSciences Holdings Corp. (IART)
14.24
+0.24
(+1.68%)
USD |
NASDAQ |
May 07, 09:43
Integra LifeSciences Holdings Cash from Investing (Quarterly) : -14.85M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Baxter International, Inc. | -133.00M |
| Stryker Corp. | -185.00M |
| Globus Medical, Inc. | -111.45M |
| Enovis Corp. | -12.99M |
| ClearPoint Neuro, Inc. | 1.088M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 9.803M |
| Cash from Financing (Quarterly) | 8.297M |
| Free Cash Flow | -10.12M |
| Free Cash Flow Per Share (Quarterly) | -0.0656 |
| Free Cash Flow to Equity (Quarterly) | -11.31M |
| Free Cash Flow to Firm (Quarterly) | 46.41M |
| Free Cash Flow Yield | -0.92% |